og:description Medical journals are relied on as trusted sources of medical information. For years, authors’ conflicts of interest—both disclosed and undisclosed— have repeatedly undermined the credibility of the medical profession and the medical literature. More
Congress tapped a national academies committee to examine a drug cost issue. It got a report that includes “egregious” failures to disclose conflicts of interest. More
Aggressive sales tactics have allegedly led surgeons to use defective or wrong-size implants, screws or other products on patients, including former Olympian Mary Lou Retton. More
Patient advocacy organizations need to shift their paradigm from "any drug at any cost" to "the best drug at the right cost." More
Disinfecting surfaces does little to curb Covid's spread. So why are two big health nonprofits working with Clorox? More
Although most well-known patient organizations have important missions and provide invaluable services to patients, many appear unable or unwilling to take positions on consumer issues such as lowering prescription drug prices that might anger their drug corporation funders.
Federal officials say that some of the money changing hands has corrupted doctors and endangered patients. More
STAT’s findings provide an unprecedented look at drug industry influence in state capitols across the 2020 election cycle. More
Many physicians' bonuses, 73% per data from 2019-2020, are tied to relative value units (RVUs), which measure time, skill and effort for each patient a physician sees. Fewer physician bonuses are tied to quality-of-care measures, or protocols and processes that encourage increased patient safety measures and decreased death rates. More
Hospital chiefs and trustees defend this as boosting public-private partnerships, but critics say these board positions — some paying millions of dollars — raise troubling issues of conflict of interest and hospital priorities. More
The Surgeon General nominee will only treat corporate America's woes More
Pharma companies have inked a series of federal settlements over payments to charity organizations, which the federal government argues are a “conduit” to boosting drug sales. Now, after an opioid investigation, two Senators want all those charity payments disclosed publicly. More
Pharmaceutical interaction in US residencies is common. This study explores the extent and type of learner interactions in US family medicine residencies with the pharmaceutical industry and compares interactions from 2008, 2013, and 2019. More
New research confirms what drug companies have long known: Industry cash and gifts influence how doctors prescribe drugs for their patients. More
A Trump administration maneuver allows executives who are leading the federal effort to keep investments in drug companies that would benefit from the pandemic response. More
A federal watchdog agency has issued an unusual warning to the drug industry to avoid using speaker programs to boost prescriptions. More
In 2017, 12 of the 19 largest pharmaceutical and biotech companies in the world reportedly had at least 1 member of the board of directors who also served a leadership role at a nonprofit AMC. More
The administration calls Moncef Slaoui, who leads its vaccine race, a “contractor” to sidestep rules against personally profiting from government positions. Slaoui owns $10 million in stock of a company working with his team to develop a vaccine. More
Industry payments can encourage the uptake of new medicines and devices in some of the most influential medical institutions in the country. More
When nonprofit medicine and nitty-gritty capitalism mix, the potential for financial conflicts abound. More